| Data characteristics | date | Data characteristics | date |
| Pr/Cr 0.437 g/mg | 10/7/2022 | Pr/Cr 0.535 g/mg | 12/05/2019 |
| Albumin 3.3 g/dl | Albumin 1.8 g/dl | ||
| B/C 11/0.9 mg/dl | B/C 8/0.8 mg/dl | ||
| eGFR > 90 ml/min |
| ||
| Pr/Cr < 0.086 | 7/15/2022 | Pr/Cr 7.947 g/mg | 10/29/2019 |
| Albumin 2.1 g/dl | Albumin 0.9 g/dl | ||
| B/C 10/0.7 mg/dl | B/C 45/0.9 mg/dl | ||
| eGFR > 90 ml/min | eGFR > 90 ml/min | ||
| Pr/Cr < 0.086 g/mg | 5/12/2022 | Pr/Cr 0.080 g/mg | 08/13/2019 |
| Albumin 2.1 g/dl | Albumin 2.9 g/dl | ||
| B/C 10/0.7 mg/dl | B/C 9/0.8 mg/dl | ||
| eGFR > 90 ml/min | eGFR > 90 ml/min | ||
| Pr/Cr 0.098 g/mg | 08/26/2021 | Pr/Cr < 0.165 g/mg | 03/15/2019 |
| Albumin 2.9 g/dl | Albumin 3.0 g/dl | ||
| B/C 10/0.8 mg/dl | B/C 7/0.8 mg/dl | ||
| eGFR > 90 ml/min | eGFR > 90 ml/min | ||
| Pr/Cr 0.081 g/mg | 12/03/2020 Patient started on rituximab for recurrent relapses | MCD resolved on steroids. | 2/2018 (first relapse on 7/2018. |
| Albumin 2.9 g/dl | |||
| B/C 8/1.0 mg/dl | |||
| eGFR 74 ml/min | |||
| Pr/Cr 2.660 g/mg | 11/09/2020 | Pr/Cr 0.437 g/mg | 10/24/2018 |
| Albumin 1.5 g/dl | Albumin 3.3 g/dl | ||
| B/C 13/1.0 mg/dl | B/C 9/0.8 mg/dl | ||
| eGFR 74 ml/min | eGFR > 90 ml/min | ||
| Pr/Cr 9.149 g/mg | 10/20/2020 | Pr/Cr 0.093 g/mg | 08/12/2018 |
| Albumin 1.4 g/dl | Albumin 3.0 g/dl | ||
| B/C 12/1.0 mg/dl | B/C 11/1.0 mg/dl | ||
| eGFR 74 ml/min | eGFR 75 ml/min | ||
| Pr/Cr 0.040 g/mg | 3/02/2020 | Pr/Cr 0.068 g/mg | 02/27/2018 |
| Albumin 3.6 g/dl | Albumin 3.0 g/dl | ||
| B/C 7/0.8 mg/dl | B/C 12/0.9 mg/dl | ||
|
| eGFR 84 ml/min |